Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

carina_web

Living with fibromyalgia

September 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing fibromyalgia, patient experience

Scottish comedian Carina MacLeod recounts her life with fibromyalgia and the benefits of comedy in dealing with a chronic condition, …
Feature
novartis_outside_1

Novartis doubles down on Cosentyx’s efficacy in psoriasis with extensive real-world data

September 13, 2018 Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis was yet another company to reveal new data on a psoriasis drug at the European Academy of Dermatology and …
News
celgene_1_02

Celgene’s Otezla produces “meaningful benefits” beyond traditional metrics in plaque psoriasis

September 13, 2018 Research and Development Celgene, otezla, pharma, psoriasis

Celgene made its voice heard amongst the chorus of new psoriasis data emerging from the European Academy of Dermatology and …
News
janssen_latest_logo_on_sign

Phase 3 data presents strong case for switching from Humira to Janssen’s Tremfya in plaque psoriasis

September 13, 2018 Research and Development Humira, Janssen, Tremfya, pharma, psoriasis

Janssen has unveiled new Phase 3 data derived from two separate trials on the efficacy and benefits of switching to …
News

Takeda set to move from Deerfield Illinois, 1000 jobs affected

September 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois

Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its …
News
john_nason

Teva names new President, TAPI and Biologics Operations

September 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Novartis, Teva, appointment

Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …
Appointment
shutterstock_159488225

Merck KGaA and Pfizer’s combo impresses in first-line treatment of advanced kidney cancer

September 12, 2018 Research and Development, Sales and Marketing Cancer, Kidney cancer, Merck KGaA, Pfizer, pharma

Bavencio (avelumab), Merck KGaA and Pfizer’s human anti-programmed death ligand-1 (PD-L1) antibody, combined with the latter’s Inlyta (axitinib) has shown …
News

BMS’ investigational psoriasis drug hits primary endpoint in skin clearance at Phase 2

September 12, 2018 Research and Development BMS, BMS-986165, Bristol-Myers Squibb, pharma, psoriasis

Bristol-Myers Squibb has unveiled new Phase 2 data for its investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, known as …
News
injection

More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter

September 12, 2018 Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …
News
14680814113_e81affc144_z_1

UK Health Secretary Matt Hancock rallies against ‘rip off’ pharma companies

September 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Matt Hancock, NICE, Vertex, pharma, pricing

British Health Secretary Matt Hancock has said that pharmaceutical companies are trying to “rip off taxpayers” and that big business …
News

Protesters in Manchester call on NICE to approve Biogen’s $750,000 drug Spinraza

September 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Spinraza, approval, protest, sma

Protesters in Manchester have called on the National Institute of Health and Care Excellence (NICE), to overturn their rejection of …
News
s712_phe_sign_960x640

UK health improving but challenges of an ageing population remain, says PHE report

September 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Public Health England, UK, pharma

A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the …
News
6127243966_e9189f1099_z

PhRMA blames hospitals for rising drug prices, hospitals association responds

September 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Drug pricing, PhRMA, hospitals, pharma

The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the …
News

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …
News

Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit

September 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles

Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025